Today: 30 June 2026
Browse Category

ASX:WTC 4 February 2026 - 12 May 2026

Australia Stock Market Today: ASX 200 Falls as Banks Drop Before Budget, Miners Rally on Copper

Australia Stock Market Today: ASX 200 Falls as Banks Drop Before Budget, Miners Rally on Copper

Australian shares slipped for a third session in a row Tuesday, weighed down by falls in banks, tech names and CSL. Investors trimmed exposure ahead of a federal budget that could shake up property, tax, and inflation policy. The S&P/ASX 200 shed 31.1 points, or 0.36%, to finish at 8,670.7. Decliners outnumbered advancers 200 to 86 on the wider S&P/ASX 300. Timing was key here. Treasurer Jim Chalmers was set to hand down the budget at 19:30 AEST. Treasury figures put the budget bottom line A$44.9 billion ahead of the forecasts made in December. Market watchers expect the budget to touch on capital gains tax discounts and tweak negative gearing—allowing property investors to write off rental losses against taxable income.
12 May 2026
········
Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

Australia Stock Market Today: ASX 200 Ends at Five-Week High as Banks Offset Tech Rout

Australian stocks managed a modest climb on Thursday, with the S&P/ASX 200 ending 0.2% higher at 8,973.20—a level not seen since March 3. Banks did most of the heavy lifting for the benchmark, though steep losses among tech names limited further gains. The market stayed close to the 9,000 mark after Wednesday’s 2.6% surge—the sharpest one-day rise in a year—when that unexpected U.S.-Iran ceasefire sent oil briefly under $100 a barrel and sparked renewed interest in battered shares. Australian stocks had dropped roughly 8% in March, making this bounce particularly swift.
9 April 2026
···········
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 03.04.2026

LIVEMarkets rolling coverageStarted: April 3, 2026, 12:00 AM EDTUpdated: April 3, 2026, 11:59 PM EDT Hudbay Minerals (TSX:HBM) Seen as Undervalued Despite Mixed Recent Performance April 3, 2026, 11:57 PM EDT. Hudbay Minerals (TSX:HBM) has delivered a strong 1-year total shareholder return exceeding 200%, with recent 7- and 90-day gains of 11.4% and 9%, respectively. Trading at CA$30.09, the stock is viewed as undervalued by some analysts who peg fair value at CA$41.74, citing growth from its Copper World project and strategic joint ventures aiming to boost annual copper output by over 50%. Hudbay benefits from increasing demand in electrification
3 April 2026
··
WiseTech Global share price sinks 5% as tariff jitters hit ASX tech ahead of results

WiseTech Global share price sinks 5% as tariff jitters hit ASX tech ahead of results

Sydney, Feb 23, 2026, 18:11 AEDT — Market shut its doors for the day. WiseTech Global Ltd slid 5.2% to finish at A$44.63 on Monday, ranking among the bigger losers during a punishing day for Australian tech. The S&P/ASX 200 Information Technology index sank 4.5%, with the broader ASX 200 off 0.61% at 9,026. According to MarketIndex, investor anxiety over valuations and the risk of AI-driven upheaval fueled the selloff. Megaport plunged 17.5%, Pro Medicus fell 8.9%, and Technology One dropped 5.2%.
23 February 2026
······
Australia stock market jumps as miners rally, tech gets slammed; Xero sinks

Australia stock market jumps as miners rally, tech gets slammed; Xero sinks

Sydney, Feb 4, 2026, 21:49 AEDT — Market closed Australian shares ended Wednesday on a strong note, propelled by gains in miners and banks despite a sharp drop in tech stocks. The S&P/ASX 200 climbed 0.8% to 8,927. Materials surged 3.6% and energy rose 3.0%, while information technology plunged 9.4%. Yancoal Australia led the charge, jumping 9%, but Xero tumbled 15.9% and WiseTech Global dropped 10.7%.
4 February 2026
········
1 2

Stock Market Today

  • Telix Pharmaceuticals (ASX:TLX) tops Australian growth stocks with large insider holdings
    June 30, 2026, 3:11 AM EDT. Telix Pharmaceuticals (ASX:TLX) is at the front of Australian growth stocks with high insider ownership, seen as a sign of management confidence. The biopharma group, focused on radiopharmaceuticals in cancer imaging and care, pulled in about US$803.8 million in sales, most of that coming from the U.S. The company's market cap stands at A$5.5 billion. Telix's cancer pipeline is broad, and its commercial footing is firm. Its key products, Illuccix and Gozellix, support 2026 revenue targets of US$950-970 million. There's still risk from regulatory and pricing pressure, but insiders remain aligned, and partnerships with United Imaging and Regeneron support the growth story. Also mentioned: Lindian Resources (ASX:LIN), market cap A$1.7 billion, which is pushing ahead on a rare earths project in Malawi. Both names show that shareholder interest tracks with insider backing.
Go toTop